girentuximab
heidelberg pharmaceuticals,esteve,prometheus
['girentuximab', 'renal,(-adrenal)', 'kidney cancer']
also from 8-11 #asco23 is a poster session on kidney cancer. among the presenters is s brian shuch, md, discussing his work titled zr-dfo-girentuximab for pet/ct imaging of clear cell renal cell carcinoma. hall a. 
We are accelerating discoveries to prevent and cure cancer.